1. Home
  2. MAIA vs COPR Comparison

MAIA vs COPR Comparison

Compare MAIA & COPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

SELL

Current Price

$1.01

Market Cap

69.2M

Sector

Health Care

ML Signal

SELL

Logo Idaho Copper Corporation Common Stock

COPR

Idaho Copper Corporation Common Stock

HOLD

Current Price

$1.18

Market Cap

60.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAIA
COPR
Founded
2018
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
69.2M
60.1M
IPO Year
2022
2008

Fundamental Metrics

Financial Performance
Metric
MAIA
COPR
Price
$1.01
$1.18
Analyst Decision
Analyst Count
0
0
Target Price
$12.00
★ $15.38
AVG Volume (30 Days)
★ 246.6K
70.4K
Earning Date
11-09-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 33.33
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $609,174.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.87
$1.05
52 Week High
$3.19
$4.16

Technical Indicators

Market Signals
Indicator
MAIA
COPR
Relative Strength Index (RSI) 38.89 22.37
Support Level N/A N/A
Resistance Level $1.48 $3.63
Average True Range (ATR) 0.06 0.22
MACD -0.00 0.00
Stochastic Oscillator 23.11 12.37

Price Performance

Historical Comparison
MAIA
COPR

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of targeted immunotherapies for cancer, with an initial focus on non-small cell lung cancer (NSCLC), which represents the majority of lung cancer cases. Its asset, ateganosine (THIO, also known as 6-thio-dG or 6-thio-deoxyguanosine), is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The treatment approach involves administering THIO followed by the immune checkpoint inhibitor Libtayo (cemiplimab), which is manufactured and commercialized by Regeneron.

About COPR Idaho Copper Corporation Common Stock

Idaho Copper Corp is a USA-based company focused on exploring and developing its copper-molybdenum-silver deposit in Idaho, known as the CuMo project. The CuMo project currently consists of several federal unpatented lode mining claims and various patented mining claims. The unpatented lode mining claims and patented claims are situated in an unorganized mining district, in Boise County, Idaho, spanning Sections in Township 7N and 8N, Range 5E and 6E, Boise Meridian.

Share on Social Networks: